Condition
Tibial Meniscus Injuries
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 47/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed with results
Key Signals
2 with results75% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 2 (3)
Trial Status
Completed3
Recruiting1
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07501013Recruiting
Clinical Outcomes of Arthroscopic Surgeries for Shoulder and Knee Sports Injuries
NCT04274543Phase 2CompletedPrimary
Ultrasound-Guided Injections for Meniscal Injuries in Active-Duty Military
NCT04331002Phase 2TerminatedPrimary
Success of Long-acting Anti-inflammatories After Anterior Cruciate Ligament and Meniscal Injury
NCT03714659Phase 2CompletedPrimary
Autologous, Micro-fragmented Adipose Tissue for Meniscal Tears
NCT03371901Not ApplicableCompleted
Blood Flow Restriction Training in Patients With Weight Bearing Restrictions After Knee Surgery
Showing all 5 trials